Investor Relations

Rigel's Mission

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

Rigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

View All

Feb 20, 2020 • 7:30 AM EST

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results

Jan 13, 2020 • 7:30 AM EST

Rigel Pharmaceuticals Provides Business Update

Jan 9, 2020 • 7:30 AM EST

Rigel to Present at the 38th Annual J.P. Morgan Healthcare Conference

March 2020

View Presentation

2020 Annual Meeting of Stockholders

Add to Calendar View All

FY 2019

Fiscal Year Ended Dec 31, 2019

Earnings Release

PDF HTML

Audio

Earnings Webcast

Earnings Presentation

PDF

10-K

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Investor Contact Information

Company

Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd
South San Francisco, CA 94080